News Search Results
Apr 02, 2024, 09:00 ET Quthero Welcomes Dr. Omar Ibrahimi as Chief Medical Director
the founder and medical director of the Connecticut Skin Institute with over 20 years of experience. Dr. Ibrahimi is accredited by the American Academy of Dermatology, the American Society for Lasers in Surgery and Medicine, the American Society for Dermatologic Surgery and the American College of Mohs
More news about: Quthero, Inc.
Mar 19, 2024, 10:10 ET THE DERMATOLOGY FOUNDATION AND SKIN OF COLOR SOCIETY BESTOW THE FIRST-EVER SANOFI AND REGENERON DIVERSITY, EQUITY, AND INCLUSION MID-CAREER AWARD ON DONALD A. GLASS II, MD, PhD, FAAD
Color Society Scientific Symposium and the 60th Annual Meeting of the Dermatology Foundation, both of which took place during the recent American Academy of Dermatology Annual Meeting in San Diego, California. The Sanofi and Regeneron DEI Mid-Career Award was developed
More news about: Skin of Color Society
Mar 14, 2024, 12:29 ET AMERICAN ACADEMY OF DERMATOLOGY: HOW TO CHECK FOR BEDBUGS
AAD B-Roll Library About the AADHeadquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential and most representative of all dermatologic associations. With a membership of more
More news about: American Academy of Dermatology
Mar 13, 2024, 09:00 ET EltaMD Establishes March 13th as National Dermatologist Day, Building a Healthier Future for All
through preventive care and early detection. We are grateful for this spotlight," says Dr. Seemal R. Desai, MD, FAAD President of the American Academy of Dermatology (AAD). Since the brand's inception, EltaMD has been dedicated to making sun safety and early skin cancer detection accessible to
More news about: EltaMD
Mar 12, 2024, 08:00 ET Longbio Pharma Presented Positive Phase 1 Results for LP-003 at 2024AAD
and other autoimmune and rare diseases, proudly announced the Phase I data of LP-003 (new generation of anti-IgE antibody) at the 2024 American Academy of Dermatology Association annual meeting (2024AAD). The presentation of the poster titled "A Phase 1 study in healthy subjects of LP-003, a novel
More news about: Longbio Pharma
Mar 11, 2024, 11:00 ET 10xBio Announces Data from Interim Analysis of Phase 2b Clinical Trial Showing Superior Efficacy of Novel Drug for Submental Body Contouring
The findings were presented in a late-breaking research abstract at the 2024 American Academy of Dermatology (AAD) Annual Meeting SAN DIEGO,
More news about: 10xBio
Mar 10, 2024, 20:10 ET Ascletis Announces Poster Presentation of Phase II Study Final Results of FASN Inhibitor ASC40 for Treatment of Acne at 2024 AAD Annual Meeting
presentation of Phase II study final results of ASC40, a first-in-class fatty acid synthase (FASN) inhibitor for treatment of acne, at the 2024 American Academy of Dermatology (AAD) Annual Meeting in San Diego, the United States. The summary
More news about: Ascletis Pharma Inc.
Mar 10, 2024, 16:00 ET More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab study
showed improvement in skin clearance and itch relief. These late-breaking results from a Phase 3 study are being presented today at the American Academy of Dermatology (AAD) Annual Meeting. The lebrikizumab efficacy results from this trial are consistent with data in other Phase 3 studies, which
More news about: Eli Lilly and Company
Mar 09, 2024, 12:20 ET AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024
These data, along with findings from a Phase 3 late-breaking study on Otezla in palmoplantar pustulosis, will be presented at the 2024 American Academy of Dermatology (AAD) Annual Meeting, March 8-12 in San Diego. "These
More news about: Amgen
Mar 09, 2024, 12:05 ET Pelage Presents Late-Breaking Data at AAD 2024 Meeting Demonstrating PP405 Activates Human Hair Follicle Stem Cells Ex Vivo and in Phase 1 Clinical Study
PP405 reactivates dormant hair follicle stem cells to trigger hair growth. Data were presented in a late-breaking oral session of the American Academy of Dermatology (AAD) 2024 Annual Meeting in San Diego, titled
More news about: Pelage Pharmaceuticals
Mar 09, 2024, 12:00 ET First Presentation of Year 4 BIMZELX® (bimekizumab-bkzx) Data Showed Long-Term Maintenance of Complete Skin Clearance in Moderate-to-Severe Plaque Psoriasis
four-year efficacy and safety data in the treatment of adults with moderate-to-severe plaque psoriasis are being shared this week at the 2024 American Academy of Dermatology (AAD) Annual Meeting in San Diego, California, March 8–12.
More news about: UCB
Mar 09, 2024, 12:00 ET New data shows JNJ-2113, the first and only investigational targeted oral peptide, maintained skin clearance in moderate-to-severe plaque psoriasis through one year
to Week 52 and safety results consistent with previously reported data (FRONTIER 1 Study) in a late-breaking oral presentation at the American Academy of Dermatology 2024 Annual Meeting SAN DIEGO,
More news about: Johnson & Johnson
Mar 08, 2024, 13:02 ET Burt's Bees® Showcases Clinical Efficacy of Aloe and Prebiotic Containing Products in Addressing Common Skin Concerns
Clinical studies presented at the 2024 American Academy of Dermatology Annual Meeting demonstrate how nature-based products support the microbiome in compromised skin, while improving barrier function and hydration DURHAM,
More news about: Burt's Bees
Mar 08, 2024, 12:00 ET BIMZELX® 48-Week Phase 3 Analyses in Moderate-to-Severe Hidradenitis Suppurativa Showed Sustained Improvements in Skin Pain and Draining Tunnel Count
on skin pain and draining tunnels in adults with moderate-to-severe hidradenitis suppurativa (HS). These results are shared at the 2024 American Academy of Dermatology (AAD) Annual Meeting in San Diego, California, March 8–12.
More news about: UCB
Mar 08, 2024, 10:00 ET SEEMAL R. DESAI, MD, FAAD, ASSUMES PRESIDENCY OF THE AMERICAN ACADEMY OF DERMATOLOGY
Dallas-based board-certified dermatologist Seemal R. Desai, MD, FAAD, will begin his one-year term as president of the American Academy of Dermatology at the close of the AAD's Annual Meeting. Dr. Desai will lead the world's largest dermatologic society that represents nearly 21,000
More news about: American Academy of Dermatology
Mar 08, 2024, 10:00 ET AMERICAN ACADEMY OF DERMATOLOGY INSTALLS NEW OFFICERS, BOARD MEMBERS
/PRNewswire/ -- Two new officers and five new board members will be installed immediately upon conclusion of the 2024 Annual Meeting of the American Academy of Dermatology. The officers and board members are all board-certified dermatologists and members of the AAD, the world's largest dermatologic society
More news about: American Academy of Dermatology
Mar 08, 2024, 10:00 ET AMERICAN ACADEMY OF DERMATOLOGY: IS YOUR MARGARITA GIVING YOU A RASH?
AAD B-Roll Library About the AADHeadquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential and most representative of all dermatologic associations. With a membership of more
More news about: American Academy of Dermatology
Mar 08, 2024, 10:00 ET AMERICAN ACADEMY OF DERMATOLOGY: MILITARY MEMBERS MORE AT RISK FOR MELANOMA
AAD B-Roll Library About the AADHeadquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential and most representative of all dermatologic associations. With a membership of more
More news about: American Academy of Dermatology
Mar 08, 2024, 10:00 ET AMERICAN ACADEMY OF DERMATOLOGY: NEW TREATMENTS FOR HIV AND OTHER STIs PROVIDE HOPE FOR BETTER QUALITY OF LIFE
aad.org/findaderm. About the AADHeadquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential and most representative of all dermatologic associations. With a membership of more
More news about: American Academy of Dermatology
Mar 08, 2024, 10:00 ET Kyowa Kirin Will Present Phase 2b Post-hoc Analysis and Symposium at the American Academy of Dermatology Annual Meeting 2024
rocatinlimab (AMG 451/KHK4083), an investigational product in patients with moderate-to-severe atopic dermatitis (msAD), will be presented at the American Academy of Dermatology (AAD) 2024 Annual Meeting to be held in San Diego from March 8-12, 2024.
More news about: Kyowa Kirin
Mar 08, 2024, 08:00 ET Patient-Reported Outcomes Data from Longest Running Dermatology Study: TARGET-DERM AA Poster Presented at American Academy of Dermatology (AAD) 2024
multimedia:https://www.prnewswire.com/news-releases/patient-reported-outcomes-data-from-longest-running-dermatology-study-target-derm-aa-poster-presented-at-american-academy-of-dermatology-aad-2024-302083649.html
More news about: Target RWE
Mar 07, 2024, 10:00 ET SkinCure Oncology Unveils New Skin Cancer Treatment Technology at American Academy of Dermatology Annual Meeting in San Diego March 8-12 Booth 3555
IGSRT) for the treatment of nonmelanoma skin cancer, presented to dermatology patients as the GentleCure™ Experience, is exhibiting at the American Academy of Dermatology (AAD) annual meeting in San Diego March 8-12, and unveiling a groundbreaking
More news about: SkinCure Oncology
Mar 06, 2024, 08:03 ET AbbVie and Allergan Aesthetics to Present New Data at 2024 Annual AAD Meeting Showcasing Depth and Strength Across Dermatology and Aesthetics Portfolios
Aesthetics, an AbbVie company, today announced they will present 29 abstracts, including three late-breaking presentations, during the 2024 American Academy of Dermatology (AAD) Annual Meeting, March 8-12, in San Diego, California. The presented data across AbbVie and Allergan
More news about: AbbVie
Mar 06, 2024, 07:00 ET Sun Pharma Launches WINLEVI® (clascoterone) Cream 1% Connected TV (CTV) Ad Campaign with Dr. Sandra Lee (a.k.a. "Dr. Pimple Popper")
@SunPharma_US\ References 1 Skin conditions by the numbers. American Academy of Dermatology Association, 2021. Available at
More news about: Sun Pharma
Feb 27, 2024, 07:00 ET Pelage Pharmaceuticals Announces $16.75M Series A Financing led by GV to Revolutionize Regenerative Medicine for Hair Loss
statistically significant activation of a critical hair follicle stem cell activation marker. Translational data will be presented at the American Academy of Dermatology meeting in March. Androgenetic alopecia, also known as pattern balding, is the most common form of alopecia and accounts for more
More news about: Pelage Pharmaceuticals